T regulatory cells: Sentinels against autoimmune heart disease

Circulation Research

Volumn 99, Issue 10, 2006, Pages 1024-1026

  Cunningham, Madeleine W ^a,b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; Cardiomyopathy; Coxsackievirus; Myocarditis; T lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN G2A; INTERLEUKIN 1BETA; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COXSACKIE VIRUS; DOWN REGULATION; EDITORIAL; GRANULOMATOUS INFLAMMATION; HEART MUSCLE FIBROSIS; HISTAMINE RELEASE; IMMUNOGLOBULIN PRODUCING CELL; INTERFERON PRODUCTION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TRANSGENIC ANIMAL; UPREGULATION; VIRUS CAPSID; VIRUS MYOCARDITIS;

ANIMALS; AUTOIMMUNE DISEASES; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROVIRUS; MICE; MICE, TRANSGENIC; MYOCARDITIS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS;

EID: 33750916018     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000250832.30969.6a     Document Type: Editorial

References (42)

1. Caforio ALP, Goldman JH, Haven, AJ, Baig, KM, McKenna, WJ. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Int J Cardiol. 1996;54:157-163.
2. Brown CA, O'Connell JB. Myocarditis and Idiopathic dilated cardiomyopathy. Am J Med.1995;99:309-314.
3. Felker GM, Hu W, Hare JM, Hruban RH, Baughman KI, Kasper EK . The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine. 1999;78:270-283.
4. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol. 1987;18:619.
5. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, Olsen EG, Schoen FJ . Myocarditis. a histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:3-14.
6. Maisch B, P. Deeg, G. Liebau, and KKochsiek. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol. 1983;52:1072-1078.
7. Maisch B, Trostel-Soeder R, Stechemesser E, Berg PA, Kochsiek K. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol. 1982;48:533-545.
8. Woodruff JF. Viral myocarditis- a review. Am J Pathol. 1980;101:425-466.
9. Towbin JA, K. R. Bowles, and NEBowles. Etiologies of cardiomyopathy and heart failure. Nature Medicine. 1999;5:266-267.
10. Huber SA, Job LP , Woodruff JF. Lysis of infected myofibers by coxsackievirus B3 immune lymphocytes. Am J Pathol. 1980;98:681-694.
11. Cooper LT, Jr., Berry GJ, Shabetai R. Multicenter giant-cell myocarditis - natural history and treatment. N Engl J Med. 1997;336:1860-1866.
12. Cooper LT, Jr., Berry G J, Rizeq M, Schroeder JS. Giant cell myocarditis. J Heart Lung Transplant. 1995;14:394-401.
13. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Gatewood SJ, Njoku DB, Rose NR. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am J Pathol. 2004;165:1883-1894.
14. Fairweather D, Frisancho-Kiss S, Yusung SA , Barrett MA, Davis SE, Steele RA, Gatewood SJ, Rose NR. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J Immunol. 2005;174:261-269.
15. Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, Penninger JM, Eriksson U . T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med. 2006;203:2009-2019.
16. Li Y, Heuser J S, Kosanke SD, Cunningham MW. Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol. . 2006. In press.
17. Morad M, Davies NW, Ulrich G, Schultheiss HP. Antibodies against ADP-ATP carrier enhance Ca2+ current in isolated cardiac myocytes. Am J Physiol. 1988;255:H960-H964.
18. Schultheiss HP, Schulze K, Schauer R, Witzenbichler B, Strauer BE. Antibody-mediated imbalance of myocardial energy metabolism. A causal factor of cardiac failure? Circ Res. 1995;76:64-72.
19. Huber S, Feldman AM, Sartini D. Coxsackievirus B3 induces T regulatory cells which inhibit cardiomyopathy in TNFα transgenic mice. Circ Res. 2006;99:1109-1116.
20. Herskowitz A, Wolfgram LJ, Rose NR, Beisel KW. Coxsackievirus B3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains. J Am Coll Cardiol. 1987;9:1311-1319.
21. Wolfgram LJ, Beisel KW, Herskowitz A, Rose NR. Variations in the susceptibility to coxsackievirus B3-ionduced myocarditis among different strains of mice. J Immunol. 1986;136:1846-1852.
22. Cooper LT, Virmani R, Chapman NM, Frustaci A, Rodeheffer RJ, Cunningham MW, McNamara DM. National Institutes of Health-sponsored workshop on inflammation and immunity in dilated cardiomyopathy. Mayo Clin Proc. 2006;81:199-204.
23. Lutton CW, Gauntt CJ. Ameliorating effect of IFN-beta and anti-IFN-beta on coxsackievirus B3-induced myocarditis in mice. J Interferon Res. 1985;5:137-146.
24. Kuhl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 2003;107:2793-2798.
25. Fairweather D, Frisancho-Kiss S, Rose NR. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis. Rev Med Virol. 2005;15:17-27.
26. Fairweather D, Yusung S, Frisancho S, Barrett M, Gatewood S, Steele R, Rose NR. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication. J Immunol. 2003;170:4731-4737.
27. Rose NR. Viral damage or 'molecular mimicry'-placing the blame in myocarditis. Nat Med. 2000;6:631-632.
28. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol. 1987;139:3630-3636.
29. Kodama M, Matsumoto Y, Fujiwara M, Massani M, Izumi T, Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol. 1991;57:250-262.
30. Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T, Suzuki K, Shibata A. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res. 1994;75:278-284.
31. Fairweather D, Frisancho-Kiss S, Gatewood S, Njoku D, Steele R, Barrett M, Rose NR. Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection. Autoimmunity. 2004;37:131-145.
32. Ingram JL, Antao-Menezes A, Mangum JB, Lyght O, Lee PJ, Elias JA, Bonner JC. Opposing actions of Stat1 and Stat6 on IL-13-induced up-regulation of early growth response-1 and platelet-derived growth factor ligands in pulmonary fibroblasts. J Immunol. 2006;177:4141-4148.
33. Shevach EM. Regulatory T cells in autoimmmunity. Annu Rev Immunol. 2000;18:423.
34. Piccirillo CA, Shevach EM. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol. 2001;167:1137-1140.
35. Shevach EM, McHugh RS, Piccirillo CA, Thornton AM. Control of T-cell activation by CD4+ CD256+ suppressor T cells. Immunol Rev. 2001;182:58-67.
36. DiPaolo RJ, Glass DD, . Bijwaard KE, Shevach EM. CD4+CD25+ T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells. J Immunol. 2005;175:7135-7142.
37. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV. FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity. 2005;23:41-51.
38. Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol. 1996;70:7811-7818.
39. Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, Lipsky PE. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood. 2006;108:253-261.
40. Ono M, J. Shimizu, Miyachi Y, Sakaguchi S. Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells. J Immunol. 2006;176:4748-4756.
41. Shevach EM, Stephens GL. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol. 2006;6:613-618.
42. Sutmuller RP, den Brok MH, Kramer M, Bennink EJ, Toonen LW, Kullberg,BJ, Joosten LA, Akira S, Netea MG, Adema GJ. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest. 2006;116:485-494.